ATE526963T1 - Pharmazeutische zusammensetzung mit olmesartan- medoxomil - Google Patents

Pharmazeutische zusammensetzung mit olmesartan- medoxomil

Info

Publication number: ATE526963T1
Authority: AT; Austria
Prior art keywords: medoxomil; pharmaceutical composition; composition containing; containing olmesartan; olmesartan
Prior art date: 2006-05-04

Application number

AT06009223T

Other languages

English (en)

Inventor

Matej Avanzo

Peterka Tanja Rozman

Igor Legen

Original Assignee

Lek Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-05-04

Filing date

2006-05-04

Publication date

2011-10-15

2006-05-04 Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals

2011-10-15 Application granted granted Critical

2011-10-15 Publication of ATE526963T1 publication Critical patent/ATE526963T1/de

Links

239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 title abstract 2
UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 title abstract 2
229960001199 olmesartan medoxomil Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
230000001747 exhibiting effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT06009223T 2006-05-04 2006-05-04 Pharmazeutische zusammensetzung mit olmesartan- medoxomil ATE526963T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06009223A EP1891952B1 (de)	2006-05-04	2006-05-04	Pharmazeutische Zusammensetzung mit Olmesartan-Medoxomil

Publications (1)

Publication Number	Publication Date
ATE526963T1 true ATE526963T1 (de)	2011-10-15

Family

ID=37076372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06009223T ATE526963T1 (de)	2006-05-04	2006-05-04	Pharmazeutische zusammensetzung mit olmesartan- medoxomil

Country Status (8)

Country	Link
US (1)	US9707178B2 (de)
EP (2)	EP1891952B1 (de)
AT (1)	ATE526963T1 (de)
CA (1)	CA2651138C (de)
ES (1)	ES2388880T3 (de)
PL (1)	PL2021002T3 (de)
SI (2)	SI1891952T1 (de)
WO (1)	WO2007128478A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008001734A1 (en)	2006-06-27	2008-01-03	Daiichi Sankyo Company, Limited	Compressed preparation
EP2228066A1 (de) *	2009-03-03	2010-09-15	LEK Pharmaceuticals d.d.	Pharmazeutische Zusammensetzungen eines auf Sulphonylharnstoff basierenden pharmazeutischen Wirkstoffs mit ausgezeichneten Auflösungseigenschaften
WO2011045760A2 (en) *	2009-10-13	2011-04-21	Ranbaxy Laboratories Limited	Micronized olmesartan medoxomil compositions
CA2785920A1 (en)	2010-01-05	2011-07-14	Ratiopharm Gmbh	Solid oral dosage form containing olmesartan medoxomil
TR201005867A1 (tr)	2010-07-16	2012-02-21	Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇	Olmesartan farmasötik bileşimleri.
JP5705562B2 (ja) *	2011-01-25	2015-04-22	沢井製薬株式会社	カンデサルタンシレキセチル含有錠剤及びその製造方法
WO2014002011A1 (en) *	2012-06-26	2014-01-03	Micro Labs Limited	Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
JPWO2014188729A1 (ja) *	2013-05-24	2017-02-23	持田製薬株式会社	経口用組成物
JP6653116B2 (ja) *	2014-08-27	2020-02-26	日本ケミファ株式会社	オルメサルタンのプロドラッグ製剤
JP6765473B2 (ja) *	2019-05-09	2020-10-07	日本ケミファ株式会社	オルメサルタンのプロドラッグ製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1170214B (it) *	1983-09-12	1987-06-03	Crinos Industria Farmaco	Composizione farmaceutica per la cura delle arteriopatie periferiche
CA2229000C (en)	1991-02-21	2002-04-09	Sankyo Company, Limited	1-biphenylimidazole derivatives, their preparation and their therapeutic use
US6555139B2 (en) *	1999-06-28	2003-04-29	Wockhardt Europe Limited	Preparation of micron-size pharmaceutical particles by microfluidization
AU3408801A (en) *	2000-02-18	2001-08-27	Takeda Chemical Industries Ltd	Tnf-alpha inhibitors
EP1595540A1 (de) *	2000-11-21	2005-11-16	Sankyo Company Limited	Zusammensetzung enthaltend einen Angiotensin-II-Rezeptor-Antagonist und einen Diuretikum und deren Verwendung zur Behandlung von Bluthochdruck
JP3874419B2 (ja) *	2003-01-31	2007-01-31	三共株式会社	動脈硬化及び高血圧症の予防及び治療のための医薬
GB0325291D0 (en) *	2003-10-29	2003-12-03	Pfizer Ltd	Novel combination
WO2006000564A1 (en) *	2004-06-23	2006-01-05	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists
US20070054948A1 (en) *	2004-09-02	2007-03-08	Lilach Hedvati	Purification of olmesartan medoxomil
KR20090102883A (ko) *	2004-09-02	2009-09-30	테바 파마슈티컬 인더스트리즈 리미티드	올메살탄 메독소밀의 정제
KR100912146B1 (ko) *	2004-10-27	2009-08-14	에프. 호프만-라 로슈 아게	인돌 또는 벤즈이미다졸 유도체
US20060281800A1 (en) *	2005-04-12	2006-12-14	Glenmark Pharmaceuticals Limited	Polymorphic form of olmesartan and process for its preparation
CA2616466A1 (en) *	2005-07-29	2007-02-15	Krka	Process for the preparation of olmesartan medoxomil

2006
- 2006-05-04 SI SI200631227T patent/SI1891952T1/sl unknown
- 2006-05-04 EP EP06009223A patent/EP1891952B1/de not_active Expired - Lifetime
- 2006-05-04 AT AT06009223T patent/ATE526963T1/de not_active IP Right Cessation
2007
- 2007-05-02 PL PL07724794T patent/PL2021002T3/pl unknown
- 2007-05-02 US US12/299,237 patent/US9707178B2/en not_active Expired - Fee Related
- 2007-05-02 WO PCT/EP2007/003868 patent/WO2007128478A2/en not_active Ceased
- 2007-05-02 CA CA2651138A patent/CA2651138C/en not_active Expired - Fee Related
- 2007-05-02 SI SI200731003T patent/SI2021002T1/sl unknown
- 2007-05-02 ES ES07724794T patent/ES2388880T3/es active Active
- 2007-05-02 EP EP07724794A patent/EP2021002B1/de not_active Not-in-force

Also Published As

Publication number	Publication date
SI2021002T1 (sl)	2012-10-30
CA2651138A1 (en)	2007-11-15
EP2021002A2 (de)	2009-02-11
ES2388880T3 (es)	2012-10-19
SI1891952T1 (sl)	2012-02-29
EP1891952A1 (de)	2008-02-27
WO2007128478A3 (en)	2008-02-07
EP2021002B1 (de)	2012-05-30
CA2651138C (en)	2016-02-16
US9707178B2 (en)	2017-07-18
EP1891952B1 (de)	2011-10-05
PL2021002T3 (pl)	2012-11-30
US20090238871A1 (en)	2009-09-24
WO2007128478A2 (en)	2007-11-15

Similar Documents

Publication	Publication Date	Title
SI2021002T1 (sl)	2012-10-30	Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
ATE499090T1 (de)	2011-03-15	Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
EA201070698A1 (ru)	2011-02-28	Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
UY28756A1 (es)	2005-09-30	Compuestos
ATE459622T1 (de)	2010-03-15	Tropanverbindungen
EA201170772A1 (ru)	2012-03-30	Органические соединения
BR122013025375B8 (pt)	2021-05-25	compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
UY28755A1 (es)	2005-09-30	Compuestos
UY30481A1 (es)	2008-02-29	Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
MY148429A (en)	2013-04-30	Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
UY30316A1 (es)	2007-11-30	Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones
ECSP088871A (es)	2008-12-30	Derivados de triazolopirazina
UY30610A1 (es)	2008-05-02	Moduladores de mglur5
CL2010001348A1 (es)	2011-03-25	Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
MX2010002584A (es)	2010-03-26	Derivados de piperidina como agonistas de receptores muscarinicos.
BR112012011328A2 (pt)	2016-11-22	inibidores de akt
CR11251A (es)	2010-03-08	Depsipeptidos ciclicos y usos de los mismos
UY30393A1 (es)	2009-04-30	Derivados sustituidos de la 1-piperidin-1-il-1,3-dihidro-2h-benzimidazol-2-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
MA32776B1 (fr)	2011-11-01	Inhibiteurs de l'akt et de la p70 s6 kinase
CR20110381A (es)	2011-11-10	Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
CO6321158A2 (es)	2011-09-20	Formulacion oral
CR20110209A (es)	2011-05-27	Composición farmacéutica sólida
SV2010003723A (es)	2011-01-24	Derivados de piperidina 3,4-sustituida como inhibidores de renina
NO20085317L (no)	2009-02-05	Imidazoazepinonforbindelser
UY29486A1 (es)	2006-11-30	Compuestos utiles en terapia

Legal Events

Date	Code	Title	Description
2012-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties